Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis anion transporter 1 (SLC26A8) is a transmembrane protein encoded by the SLC26A8 gene, highly and specifically expressed in male germ cells—especially spermatocytes[1][3][5]. It is a member of the solute carrier (SLC) 26 family of anion transporters and mediates the exchange of multiple anions, most notably chloride, sulfate, bicarbonate, and oxalate across the plasma membrane[1][5]. SLC26A8 is localized primarily to the sperm flagellum and is critical for normal sperm motility, capacitation, and structural integrity of the sperm tail and annulus[1][2][5]. The protein physically and functionally interacts with the cystic fibrosis transmembrane conductance regulator (CFTR), a relationship essential for activating CFTR-dependent Cl^- and HCO₃⁻ fluxes required for the PKA-dependent phosphorylation cascades that underlie sperm motility and capacitation[1][2][4][7]. Mutations in SLC26A8, particularly compound heterozygous variants, have been related to male infertility characterized by asthenozoospermia (reduced sperm motility) and structural sperm abnormalities; however, not all variants are pathogenic, and a clear genotype-phenotype link can be complex[5]. SLC26A8 does not currently have known therapeutic drugs or interventions targeting it directly. Its clinical significance is primarily as a mechanism for idiopathic male infertility and a potential biomarker for certain infertility phenotypes[5].
Not applicable (no drugs identified targeting SLC26A8)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis anion transporter 1 (SLC26A8).